Omega Therapeutics, Inc. (OMGAQ)
OTCMKTS · Delayed Price · Currency is USD
0.0160
+0.0040 (33.33%)
Mar 13, 2025, 9:30 AM EST

Omega Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Mar '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
1166274541--
Market Cap Growth
-43.24%-39.50%-49.31%---
Enterprise Value
99208149319--
Last Close Price
0.023.015.7111.33--
PS Ratio
0.1153.64132.353758.96--
PB Ratio
0.082.862.592.70--
P/TBV Ratio
5.832.862.592.70--
EV/Sales Ratio
12.1967.1971.832215.28--
Debt / Equity Ratio
11.102.210.210.101.11-1.29
Asset Turnover
0.040.020.010.00--
Quick Ratio
1.303.005.7618.853.011.02
Current Ratio
1.613.356.2619.133.121.19
Return on Equity (ROE)
-166.90%-118.82%-66.99%-64.65%-4249.21%-
Return on Assets (ROA)
-25.01%-35.77%-33.86%-31.57%-104.69%-
Return on Capital (ROIC)
-26.72%-39.79%-36.80%-33.99%-143.17%-
Earnings Yield
-8250.97%-58.70%-37.43%-12.61%--
FCF Yield
-6506.68%-56.86%-36.41%-10.91%--
Buyback Yield / Dilution
-5.61%-12.80%-113.71%-473.56%-17.69%-
Total Shareholder Return
-5.61%-12.80%-113.71%-473.56%-17.69%-
Source: S&P Capital IQ. Standard template. Financial Sources.